- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cultivating Equality in the Garden State
In this fifth, and final, special bonus episode of our Pride Month series, we speak with Lauren Albrecht, director of advocacy and organizing, and Layla Orlando, director of health equity and wellness, at Garden State Equality, the largest lesbian, gay, bisexual, transgender, queer, plus advocacy organization in New Jersey.
Garden State Equality celebrates its 20th anniversary this year. Since its founding in 2004, it has grown to more than 150,000 members | Image Credit: Garden State Equality
Welcome to the final episode in our special Pride Month series. In this special edition of Managed Care Cast, we speak with Lauren Albrecht, director of advocacy and organizing, and Layla Orlando, director of health equity and wellness, at Garden State Equality, first founded in 2004 and which has grown to become the largest lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) advocacy organization in New Jersey, at more than 150,000 members.
Racial, economic, and disability justice concerns underpin this advocacy and civil rights organization’s mission to bring full equality to all members of all LGBTQ+ communities in the state. We discuss state- and federal-level legislation, with potential implications on not only LGBTQ+ rights in the state, but reproductive freedom as well; notable achievements for the LGBTQ+ community in New Jersey; and, as with our previous episodes in this limited-edition series, health care policy in this election year.
Please check out our previous episodes with Lancaster Pride, Rutgers, Callen-Lorde, and We Are Family.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More
